In a major breakthrough, Verve Therapeutics (VERV) has announced positive results from its Heart-2 clinical trial.…
Tag: disease
Anavex: A Small Bit Of Progress Against Alzheimer's Disease
Anavex: A Small Bit Of Progress Against Alzheimer's Disease #Anavex #Small #Bit #Progress #Alzheimer039s #Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension…
NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market
In today’s fast-paced biotech landscape, it takes more than just innovative technology to make waves –…
Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial
Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial#Experimental #Lilly #drug #cuts…
Soleno Therapeutics: A Breakthrough in Rare Disease Treatment
The biotech world is buzzing with excitement as Soleno Therapeutics (SLNO) has just received FDA approval…
Ireland adopts Maven for disease surveillance
Ireland adopts Maven for disease surveillance#Ireland #adopts #Maven #disease #surveillance
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease#Development #Prediction #Model…
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease
Tenaya Therapeutics: TN-201 Isn't The Only Shot On Goal Targeting Heart Disease #Tenaya #Therapeutics #TN201 #Isn039t…
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory…